Naturis Cosmetics funding of ₹100 crore marks the Mumbai-based contract development and manufacturing organisation’s (CDMO) first-ever external institutional round, as publicly reported on 2026-07-16. The round was led by Sharrp Ventures, which the company announced on July 16. Naturis Cosmetics operates in the beauty & personal care (BPC) space, serving brands as a contract development and manufacturing organisation.
Quick Highlights
- Founders: Rahul Tandon, Sanjay Mehra, Nukul Mehra, and Dhruv Mehra
- Lead Investor: Sharrp Ventures
- Participating Investors: Mirabilis Investment Trust (the family office of Infosys Co-founder K. Dinesh), Anicut Capital, Niveshaay, D2C ecosystem leaders including Suyash Saraf of Hyperscale Ventures and Yogesh Kabra, along with several prominent angel investors from the pharmaceutical and specialty chemicals industries
- Investor Background: Sharrp Ventures believes Naturis has the potential to become a leading product innovation and manufacturing platform serving both domestic and international beauty brands.
- Headquarters: Mumbai, Maharashtra, India
- Announcement Date: 16 July 2026
Funding Breakdown
Use of Funds
The company said the fresh capital will be used to expand its manufacturing capacity, strengthen research and development capabilities, and accelerate growth across the beauty and personal care sector. More specifically, Naturis plans to set up a 225,000 sq ft manufacturing facility in Vapi, establish an experience centre in the NCR, launch a new R&D centre in Mumbai, and expand its workforce across functions. As part of the transaction, Sagar Kandhari, Partner at Ambassador Capital Partners, advised Naturis during its fundraising process and has joined the company’s Board to support its strategic growth and expansion plans.
Funding Timeline
Naturis Cosmetics raised ₹100 crore in July 2026 in a round led by Sharrp Ventures. It is the company’s first institutional funding since it was founded in 2011. Naturis said it has recorded more than 50% revenue growth on a CAGR basis over the last four years while remaining profitable.
Expansion Plans
Over the next five years, Naturis intends to diversify into high-growth categories including men’s grooming, body care, colour cosmetics, fragrances, exports, and further strengthen its capabilities in the OTC pharmaceutical segment while expanding innovation partnerships with both existing and emerging brands. The company also plans to significantly expand its workforce across business functions. Founded as an R&D-driven CDMO, Naturis currently serves over 50 beauty and personal care brands, including Nykaa, Pilgrim, Purplle, Colorbar, Bare Anatomy, Kay Beauty, and Asaya, and collaborates with pharmaceutical companies such as Glenmark and Dr. Reddy’s Laboratories in the OTC and cosmeceuticals segments.
Significance
Naturis spent its first years compounding revenue instead of raising capital, and arrives at its first institutional round with ₹155 crore of sales and a profit in every year on record — a different starting position from a company that raised its way to scale, and it is what the new capital is being asked to accelerate rather than repair. The investment comes at a time when India’s beauty and personal care industry is witnessing rapid growth; according to a recent Redseer report, India’s BPC market is expected to reach $40 billion by 2030, making it the fourth-largest BPC market globally, driven by rising disposable incomes, increasing consumer awareness, and expanding access to premium beauty products. Every new D2C brand needs someone to actually make the product, and that is the layer Naturis sells into — positioning the company as a critical infrastructure partner within India’s booming beauty economy.
These details have been verified against multiple publicly available reports as of 2026-07-16.
Stay updated with the latest startup funding news on The Courtroom.
Disclaimer: This report is compiled from publicly available sources and is for informational purposes only; funding figures are as publicly reported and may be subject to change.
